Cellply is a deep tech company with the ambition to develop analytical tools enabling fast end effective development of life-saving cancer cell therapies. Our solutions support biopharma companies and research institutes from discovery to R&D and quality control of advanced therapies. Our team features a unique combination of expertise in a diverse set of technology going from microfluidics to robotics, AI, biology and immunology.
TEAM
Operational team

Emiliano Spagnolo
Chief Executive Officer

Massimo Bocchi
Founder and Chief Strategy Officer

Andrea Faenza
Chief Technology Officer

Laura Rocchi
Head of Biology

Dario Biscarini
Project Manager

Chantal Pozzobon
Office Manager

Laura Rambelli
Laboratory and Warehouse Specialist

Rita Ruggiano
Project Leader Analytical SW

Luca Giulianelli
Head of Control SW

Nicola Pecorari
Senior Hardware Engineer

Alice Bettelli
Project Leader Analytical Methods

Silvia Bocchi
Project Leader Assay development

Laura Gruppioni
Junior Software Developer

Mark Atlas
Marketing and US Sales
INVESTORS
GRANTS & PROJECTS

ONCOSMART
Development of an In-Vitro Diagnostic platform for functional precision medicine to predict the outcome of hematological cancer patients

COVID-19 - Regione ER
Sviluppo di un test prognostico sulla base del profilo immunitario dei pazienti con Coronavirus Disease 19 (COVID-19) ospedalizzati